Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
A study of tirzepatide (LY3298176) in participants with obesity or overweight for the maintenance of weight loss (SURMOUNT4) (NCT04660643)
The language matters
Not the bottom edge of the plunger
[13] TrumpRx Program (Now Live) TrumpRx.gov launched February 6, 2026, offering Zepbound at ~$346/month via a federal direct-to-consumer program
It is not intended to be used to treat type 1 diabetes or diabetic ketoacidosis
SC) was administered into rats for 3 consecutive days, then they were treated daily with semaglutide intraperitoneally in low (5 nmol/kg), intermediate (10 nmol/kg), or high doses (20 nmol/kg), respectively, for 14 consecutive days
US$ 21.41
US$ 25.09
US$ 24.96
US$ 23.14
.jpg_01.jpeg)
US$ 28.45
US$ 29.66
US$ 29.75
